Rockley Photonics ($RKLY) $10M Investor Settlement
Rockley Photonics has reached a $10M settlement with $RKLY investors to resolve claims that it misled them during its 2021 de-SPAC merger with SC Health by overstating its relationship with Apple and the readiness of its wearable biosensor technology.
Outline:
Rockley went public through a merger with SC Health in August 2021 while promoting its wearable biosensor technology and highlighting Apple as a key customer. Investors later alleged the company overstated both its commercial readiness and the strength of that relationship. Reports of development delays and a weaker outlook raised doubts about the company’s projections. After the stock fell sharply, investors filed suit, and Rockley later settled.
Timeline:
August 2021: Rockley merged with SC Health and began trading under $RKLY.
2021–2022: Reports surfaced that Rockley’s product development was delayed and its projections were overstated.
January 2022: $RKLY fell over 30% as investors questioned the company’s outlook.
March 2023: Investors filed suit alleging misstatements tied to the merger.
February 2026: Rockley reached a tentative settlement to resolve the claims.
Background:
Rockley Photonics entered public markets through a merger with the SPAC SC Health Corp. in 2021. During the transaction and in related disclosures, the company highlighted its wearable biosensor technology and promoted relationships with major technology companies.
The complaint alleges Rockley overstated the maturity of its technology and emphasized Apple as a major customer that validated its platform. According to the claims, however, Rockley had no revenue from Apple and its biosensor products were still pre-commercial and facing development delays.
Investors also alleged that Rockley and SC Health failed to adequately disclose risks related to cash burn, product development timelines, and limited near-term revenue visibility. As projections failed to materialize and concerns about the company’s outlook increased, the stock declined significantly.
What Can Investors Expect Now?
Rockley Photonics has reached a settlement with $RKLY investors to resolve claims tied to statements about its Apple relationship and the readiness of its biosensor technology during its 2021 de-SPAC merger.
If you were damaged due to this situation, you can file for a payout and get your share of the settlement. You can check if you are eligible and other details in the FAQ section.
Frequently Asked Questions
All persons and entities who purchased or otherwise acquired Rockley Photonics Holdings Ltd. (“RKLY”) securities — including Rockley ordinary shares and Rockley warrants (RKLY.W) — during the Class Period of August 11, 2021 through January 23, 2023, and were damaged thereby.
No, if you have purchased securities within the class period, you are eligible to participate.
You can participate in the settlement and retain (or sell) your securities.
The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
The final payout amount depends on your specific trades and the number of investors participating in the settlement.
If 100% of investors file their claims - the average payout will be $0.11 per share. Although typically only 25% of investors file claims, in this case, the average recovery will be $0.44 per share.
If you're eligible, you can file your claim directly from this case page by clicking the "Collect Payout" button.
More than 100 companies are currently paying out settlements. Connect your brokerage account to automatically check which ones you may have missed — or file manually for this case.
11th.com is an investor recovery company that helps investors track and collect securities class action settlements. We will:
1. Prepare documents for your payout.
2. Audit the claim and make sure you get the maximum possible payout.
3. File a claim with the settlement administration.
4. Correspond with the settlement administration to resolve emerging issues.
5. Deliver payout directly to your brokerage account.
There is no upfront cost, but we will deduct 20% of the recovered amount as a commission for our services.